DSM-Firmenich AG/€DSFIR
1D1W1MYTD1Y5YMAX
Capital at risk
About DSM-Firmenich AG
DSM-Firmenich AG, established in May 2023 through the merger of Dutch company DSM N.V. and Swiss company Firmenich SA, operates in the nutrition, health, and beauty industries. The company is organized into four segments: Perfumery & Beauty, offering fragrance solutions; Taste, Texture & Health, providing food and beverage ingredients; Health, Nutrition & Care, delivering dietary supplements and medical nutrition products; and Animal Nutrition & Health, supplying animal feed ingredients. Headquartered in Kaiseraugst, Switzerland, and Maastricht, Netherlands, DSM-Firmenich has operations in nearly 60 countries and employs approximately 30,000 people. The merger combines DSM's expertise in health and nutrition with Firmenich's capabilities in perfumery and taste, positioning the company to offer integrated solutions across its sectors. (,)
- Ticker
- €DSFIR
- Sector
- Materials
- Primary listing
- AEX
- Employees
- 20,786
- Headquarters
- Kaiseraugst, Switzerland
- Website
- www.dsm-firmenich.com
DSM-Firmenich AG Metrics
BasicAdvanced
€23B
-
-€5.56
0.56
€2.50
0.92%
Price and volume
Market cap
€23B
Beta
0.56
52-week high
€96.62
52-week low
€55.38
Average daily volume
703K
Dividend rate
€2.50
Financial strength
Current ratio
1.746
Quick ratio
0.816
Long term debt to equity
28.452
Total debt to equity
37.638
Interest coverage (TTM)
4.08%
Profitability
EBITDA (TTM)
1,310
Gross margin (TTM)
39.18%
Net profit margin (TTM)
-15.23%
Operating margin (TTM)
6.80%
Effective tax rate (TTM)
23.55%
Revenue per employee (TTM)
€440,000
Management effectiveness
Return on assets (TTM)
1.23%
Return on equity (TTM)
1.87%
Valuation
Price to revenue (TTM)
2.605
Price to book
1.31
Price to tangible book (TTM)
9.03
Price to free cash flow (TTM)
28.597
Free cash flow yield (TTM)
3.50%
Free cash flow per share (TTM)
3.265
Dividend yield (TTM)
2.68%
Forward dividend yield
0.92%
Growth
Revenue change (TTM)
22.38%
Earnings per share change (TTM)
-312.75%
3-year revenue growth (CAGR)
1.17%
10-year revenue growth (CAGR)
1.53%
3-year earnings per share growth (CAGR)
-33.87%
10-year earnings per share growth (CAGR)
13.78%
3-year dividend per share growth (CAGR)
16.04%
10-year dividend per share growth (CAGR)
4.24%
Bulls say / Bears say
DSM-Firmenich beat market expectations for Q2 core earnings, sending shares up 11% on Europe’s STOXX 600 index. (Reuters)
CEO Dimitri de Vreeze said the company expects full-year like-for-like sales growth to reach the upper end of its 2–4% target range, driven by broad-based volume growth. (Reuters)
A restructuring program targeting roughly 1,000 position cuts is projected to generate €100 million in recurring annual savings, supporting margin expansion. (Reuters)
Divestment of the Animal Nutrition & Health unit to CVC for €2.2 billion narrows DSM-Firmenich’s business scope, increasing reliance on its remaining consumer-focused segments. (Bloomberg)
Temporary uplift from Middle East conflict-related supply disruptions may prove short-lived, exposing underlying demand weakness in the chemicals sector as warned by Germany’s VCI. (Reuters)
CEO Dimitri de Vreeze cautioned that fragrance growth is set to moderate to a high-single-digit pace in H2 2026, indicating a slowdown in the key Perfume & Beauty segment. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 26 Aug 2026.
Upcoming events
No upcoming events
Funds containing DSM-Firmenich AG
AllEURGBPUSD
Fund name | Fund size | €DSFIR weighting |
|---|---|---|
iShares STOXX Europe 600 Food & Beverage€EXH3 | €314M | 3.62% |
iShares EURO STOXX Mid€DJMC | €572M | 1.80% |
iShares EURO STOXX Mid Cap£DJMC | £491M | 1.80% |
iShares AEX€IAEX | €778M | 1.74% |
iShares AEX£IAEX | £668M | 1.74% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.